Gross margin of the leading manufacturers of human vaccines in China 2011
The statistic shows the gross margin of the leading manufacturers of human vaccines in China in 2011. The gross margin is calculated by deducting manufacturing costs from revenue. It is predominantly expressed in percent of sales. The gross margin does not include the costs incurred in research and development and marketing processes. In 2011, the gross margin of vaccine manufacturer Zhifei Biological amounted to 58.89 percent.
